IDEXX Laboratories
Prix: 560.88Entreprise et modèle économique
IDEXX Laboratories is a global leader in veterinary diagnostics and software solutions. The company develops and manufactures a range of products for animal health, including diagnostic tests, instruments, and software for veterinary practices. Its major business segments include Companion Animal Group, Livestock, and Poultry, with the primary revenue source coming from diagnostic products and services for pets and livestock. IDEXX also offers water testing solutions and diagnostic products for dairy and poultry industries.
Profil d’investissement
The investment profile of IDEXX Laboratories is more aligned with growth investors, given its focus on innovation and expansion in the veterinary diagnostics market. The company has shown consistent revenue growth, although it faces higher risk factors. Investors seeking a balanced approach may find it suitable, but the absence of dividends may deter those focused on income.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 13.67 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 4.6% ↑
- Surprise BPA
- 1.8% conforme
- Volatilité 20 j
- 1.7% stable
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-13 02:40 | Vendre | Conserver | Mixed performance; cautious due to negative momentum. |
| 2026-06-03 02:43 | Conserver | Vendre | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:41 | Vendre | Conserver | Weak momentum and high risk; cautious outlook advised. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-04-28 12:16 | UBS | Objectif abaissé | 730 → 640 | 569.167 |
| 2026-02-09 11:54 | Piper Sandler | Objectif abaissé | 775 → 750 | 644.61 |
| 2026-02-05 10:41 | Barclays | Objectif abaissé | 850 → 800 | 642.94 |
Rien pour le moment